Tigerlily Foundation and Labcorp collaborate to increase clinical trial diversity for women of color

BURLINGTON, N.C. & ALDIE, Va. --(BUSINESS WIRE)--Jun. 24, 2022-- Labcorp , a leading global life sciences company, and Tigerlily Foundation (Tigerlily), a leading breast cancer patient advocacy organization, today announced a new collaboration to increase clinical trial diversity for women of color

Labcorp enhances clinical trial and drug development capabilities through real-world data collaboration with HealthVerity

BURLINGTON, N.C. --(BUSINESS WIRE)--Jun. 21, 2022-- Labcorp ® (NYSE: LH), a leading global life sciences company, today announced a new collaboration with HealthVerity , Inc., the leader in Identity, Privacy, Governance, and Exchange (IPGE) for real-world data (RWD), that will expand Labcorp’s comprehensive, end-to-end drug development and clinical trial programs.

Media Statement: Labcorp receives FDA Emergency Use Authorization for first COVID-19 test to identify specific SARS-CoV-2 lineages

BURLINGTON, N.C.,  June 14, 2022 — On Friday, June 10, 2022, Labcorp, a global life sciences company, received an emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its VirSeq SARS-CoV-2 NGS (next-generation sequencing) Test on the PacBio Sequel II sequencing system.